Holen Sie sich die Stockscreener-App
7.33
0.83%
0.06
Schlusskurs vom Vortag:
$7.27
Offen:
$7.3599
24-Stunden-Volumen:
5,985
Relative Volume:
0.53
Marktkapitalisierung:
$20.76M
Einnahmen:
$20.92M
Nettoeinkommen (Verlust:
$-25.87M
KGV:
-0.3724
EPS:
-19.6815
Netto-Cashflow:
$-15.02M
1W Leistung:
-7.16%
1M Leistung:
-2.91%
6M Leistung:
+43.69%
1J Leistung:
-0.03%
1-Tages-Spanne:
$7.19
$7.37
1-Wochen-Bereich:
$7.1732
$7.99
52-Wochen-Spanne:
$4.14
$10.56
Lifeward Ltd Stock (LFWD) Company Profile
Firmenname
Lifeward Ltd
Sektor
Branche
Telefon
15082511154
Adresse
2 CABOT ROAD, HUDSON
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
7.33 | 20.59M | 20.92M | -25.87M | -15.02M | -19.68 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-10 | Eingeleitet | Laidlaw | Buy |
| 2017-04-03 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Eingeleitet | Oppenheimer | Outperform |
| 2016-07-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-05-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Bestätigt | Barclays | Equal Weight |
| 2014-10-07 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Lifeward Ltd Aktie (LFWD) Neueste Nachrichten
H.C. Wainwright reiterates Lifeward stock rating on revenue growth - Investing.com
Lifeward Q2 revenue rises 16% to $6.6 million - grafa.com
Lifeward earnings missed by $0.07, revenue topped estimates - Investing.com Canada
Lifeward Ltd. Announces Resignation of Almog Adar from Chief Financial Officer, Effective September 30, 2026 - marketscreener.com
Lifeward Ltd. Announces Stepping Down of Board Members, Effective August 13, 2026 - marketscreener.com
Lifeward Q2 revenue beats estimates; adjusted EPS misses consensus - scanx.trade
Lifeward Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Lifeward Ltd. 2026: Revenue $6.62M, Net income ($11.52M), EPS ($4.12) — 10-Q Summary - TradingView
Lifeward (NASDAQ: LFWD) doubles H1 loss and warns on going concern as it adds debt - Stock Titan
Is Lifeward Ltd (LFWD) Positioned for Growth After Q2 Earnings? - GuruFocus
Lifeward: Q2 Earnings Snapshot - kens5.com
Form 8K Lifeward Ltd. For: 14 August By Investing.com - Investing.com Nigeria
Lifeward Ltd Q2 revenue up 16% on higher ReWalk Personal exoskeleton sales - TradingView
Lifeward Revenue Rises 16% to $6.6 Million in Second Quarter 2026 - Quiver Quantitative
Lifeward (LFWD) grows Q2 2026 revenue 16% as net loss deepens on non-cash charges - Stock Titan
Lifeward Reports 16% Second-Quarter Revenue Growth and Strengthened Balance Sheet Amid Commercial Expansion - quiverquant.com
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth - The Manila Times
Lifeward’s CFO to Depart Sept. 30 as Three Directors Step Down - Stock Titan
Lifeward (LFWD) Advances 1.87% to $7.89, Holding Above Key SupportSafe Entry Stocks - Vinanet
Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside - Yahoo Finance
LFWD Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Share UptickTrough Earnings Signal - Vinanet
Lifeward Ltd expected to post a loss of $1.34 a shareEarnings Preview - TradingView
LFWD Q1 2026 Earnings: Wider-than-Expected Loss Signals Rising Cost and Execution PressuresDividend Earnings Report - Vinanet
Lifeward Ltd. SEC Filing (Aug 11, 2026) - Stock Titan
Oramed Pharmaceuticals (NASDAQ: ORMP) pivots to investment model with $116M profit - Stock Titan
Lifeward Ltd (LFWD) Stock News Today - TradingKey
Lifeward to report Q2 2026 financial results on August 14, no conference call planned - Pluang
Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Lifeward Out With Q2 Numbers - Baystreet.ca
Lifeward to issue Q2 results before 9:30 a.m. Aug. 14; no call - Stock Titan
Lifeward Ltd. (LFWD) Holds Ground Near $7.28 as Shares Trade Within Narrow RangeBollinger Expansion - dars.gov.et
Lifeward Launches ReWalk 7 Pilot Program with Ottobock Care to Expand U.S. Patient Access - Quiver Quantitative
A six-month pilot aims to bring Lifeward's ReWalk 7 to more patients - Stock Titan
LFWD Q2'26 Earnings: revenue estimate is 6.53M USD - TradingView
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton - The Manila Times
Form S-3 Lifeward Ltd. For: 3 August By Investing.com - Investing.com South Africa
LFWD|Lifeward Ltd|Price:7.140|Chg%:-0.080 - TradingKey
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 - Stock Titan
LFWD Q1 2026 Earnings: Significant EPS Miss Sends Shares LowerEarnings Surprise Stocks - Vinanet
Lifeward Ltd (LFWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lifeward Ltd (LFWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LFWD|Lifeward Ltd|Price:7.050|Chg%:-0.105 - TradingKey
Lifeward Ltd (LFWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lifeward Ltd (LFWD) Income Statement - TradingKey
Lifeward Ltd (LFWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lifeward Ltd. Revenue Breakdown – LS:A12BMB - TradingView
Lifeward Ltd (LFWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lifeward Ltd (LFWD) Balance Sheet - TradingKey
Lifeward Ltd (LFWD) Cash Flow - TradingKey
Lifeward Ltd (LFWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Finanzdaten der Lifeward Ltd-Aktie (LFWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):